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Replicationse (3CLpro) plays important roles in viral life cycle through extensive processing of
the polyproteins 1a and 1ab into 12mature, non-structural proteins (nsp5–nsp16). Structural and biochemical
studies have revealed that all conﬁrmed 3CLpro cleavage sites have a conserved Gln residue at the P1 position,
which is thought to be absolutely required for efﬁcient cleavage. Recent studies on murine hepatitis virus
(MHV) showed that processing of the 1a polyprotein at the position between nsp10–nsp11 is essential for viral
replication. In this report, we investigated the requirement of processing at the equivalent position for
replication of avian coronavirus infectious bronchitis virus (IBV), using an infectious cloning system. The results
showed thatmutation of the P1 Gln to Pro or deletion of the Gln residue in the nsp10–nsp11/12 site completely
abolished the 3CLpro-mediated processing, but allowed production of infectious recombinant viruses with
variable degrees of growth defect, suggesting that cleavage at the nsp10–nsp11/12 site of IBV is dispensable for
viral replication in cultured cells. This studywould pave away for potential vaccine development bygeneration
of attenuated IBV from ﬁeld isolates through manipulation of the nsp10–nsp11/12 cleavage site. Similar
approaches would be also applicable to other human and animal coronaviruses.
© 2008 Elsevier Inc. All rights reserved.Introduction
Coronavirus-encoded 3C-like proteinase (3CLpro), also known as
main proteinase, plays a pivotal role in viral replication. It mediates
cleavage of the replicase polyproteins 1a and 1ab at 11 speciﬁc sites,
generating 12 mature non-structural proteins (nsp) (from nsp5–16)
and, probably, functional intermediates involved in the replication
and transcription of viral RNA (Ziebuhr et al., 2000; Ziebuhr, 2005;
Masters, 2006). The substrate speciﬁcity of coronavirus 3CLpro is
determined mainly by the P1, P2 and P1′ positions. Comparative
analyses of 77 cleavage sites of 3CLpro from seven coronaviruses
suggest amino acid conservation at the P2 (Leu, Val, Ile, Phe, and Met),
P1 (Gln) and P1′ (Ser, Ala, Gly, Asn, and Cys) positions. Among them,
the P1 position is exclusively occupied by a Gln and the bulky
hydrophobic residues (mainly Leu) are dominant at the P2 position
(Ziebuhr et al., 2000; Thiel et al., 2003; Gao et al., 2003). Insights into
the catalytic activity and substrate speciﬁcity of 3CLpros obtained by
recent determination of the crystal structure of 3CLpros from
coronavirus transmissible gastroenteritis virus (TGEV), human cor-
onavirus 229E (HCoV-229E), severe acute respiratory syndromeell Biology, 61 Biopolis Drive,
l rights reserved.coronavirus (SARS-CoV) and infectious bronchitis virus (IBV) conﬁrm
the necessity of conservation at the P1 position of the substrates
(Anand et al., 2002, 2003; Yang et al., 2003; Xue et al., 2008).
IBV, a member of the group 3 coronavirus, contains a 27.6 kb of
genomic RNA. Its replicase gene encodes two large overlapping ORFs
(1a and 1b) at the 5′-end of the genome, and translation of the
replicase gene yields polyproteins 1a of 441 kDa and 1ab of 741 kDa
via a (−1) ribosomal frameshifting (Boursnell et al., 1987; Brierley et
al., 1987, 1989). The two polyproteins are processed extensively by
virus-encoded papain-like proteinase (PLP) and 3CLpro to produce
15 mature functional products and multiple intermediates asso-
ciated with viral replication (Gorbalenya et al., 1989; Tibbles et al.,
1996; Liu et al., 1994, 1995, 1997, 1998; Liu and Brown, 1995; Ng and
Liu, 1998, 2000, 2002; Lim and Liu, 1998; Lim et al., 2000; Xu et al.,
2001) (Fig. 1a). Like its homologs in other coronaviruses, the IBV
3CLpro is encoded by ORF1a and resides in nsp5. The proteinase
mediates speciﬁc cleavage of IBV polyproteins 1a and 1ab at 11 sites
to produce 12 mature products (Fig. 1a).
In recent years, the structures and functions of coronavirus nsp are
emerging (Bartlam et al., 2007). However, the exact roles and
necessity of 3CLpro-mediated processing at individual cleavage sites
as well as the functions of speciﬁc cleavage intermediates in the life
cycle of a given coronavirus are poorly understood. In a recent study,
proteolytic processing at the cleavage sites between nsp6–nsp7, nsp7–
176 Rapid Communicationnsp8, nsp8–nsp9, and nsp10–nsp11 of murine hepatitis virus (MHV)
was shown to be essential for replication of MHV in cultured cells
(Deming et al., 2007). In this report, we used an established reverse
genetic system to investigate the requirement of processing at the
position between nsp10–nsp11/12 for IBV replication. In contrast to
the results reported by Deming et al. (2007) for MHV, mutation or
deletion of the conserved P1 Gln residue (Gln3928) showed that
proteolytic processing of the IBV polyproteins 1a and 1ab at this
position is dispensable for virus replication in cultured cells. Mutation
of the Gln3928 residue to Pro (Q3928P) or deletion of Gln3928
(ΔQ3928) completely abolished the 3CLpro-mediated processing at
the position, but allowed recovery of mutant viruses with no
detectable cleavage at the position between nsp10–nsp11/12 in cells
infected with the recovered mutant viruses. The mutant viruses
showed variable degrees of growth defect, revealing a potential way
for generation of attenuated viruses for vaccine development.
Result and discussion
Deletion and mutational analysis of the Q3928–S3929 cleavage site
between nsp10 and nsp11/12 of IBV
Introduction of point mutation and deletion into the P1 position of
the IBV 3CLpro cleavage site between nsp10 and nsp11/12 was carriedFig.1. (a) IBV genome organization and proteolytic processing of IBV replicase polyproteins. Sh
are designated non-structural proteins (nsp) 2 to nsp11, and those of polyprotein 1ab are desi
with black arrow. The cleavage sites of papain-like proteinase (PLP) are indicated with block
nsp10–nsp11/12. Plasmids carrying wild type and mutant IBV sequences from nucleotides 1
were co-expressed with the IBV 3CLpro in Vero cells using the vaccinia virus-T7 system. Cell
SDS-PAGE. Western blot was performed using anti-FLAG antibody. The cleaved product (9.1out either by replacing the P1 Gln residue with a Pro (Q3928P) and an
Asn (Q3928N), respectively, or by deleting the P1-Gln (ΔQ3928) (Fig.
1a). To check the effect of these manipulations on the cleavability of
the substrate, IBV sequence (12100–12719 nucleotide) ﬂanking this
cleavage site was ampliﬁed by RT-PCR, and cloned into a vector in
frame with a FLAG tag at the N-terminus (Fig. 1a). To facilitate
detection of the cleavage products, an additional T was inserted
between nucleotides 12347 and 12348, resulting in the extension of
the ORF1a frame to the end of the fragment (nucleotide position
12719) (Fig. 1a). To analyze the 3CLpro-mediated processing, IBV
3CLpro was co-expressed with the mutant constructs in Vero cells
using the recombinant vaccinia virus/T7 system. Western blotting
analysis with anti-FLAG antibody showed that 3CLpro was able to
completely cleave the wild type substrate; a cleavage product with
predicted molecular mass of 9.1 kDa was detected (Fig. 1b, lane 2).
However, the enzyme failed to process the mutant substrates, as the
same cleavage product was not detected in cells co-expressing 3CLpro
and the three mutant constructs (Fig. 1b, lanes 3–5).
Introduction of the point mutations (Q3928N and Q3928P) and deletion
(ΔQ3928) into the IBV genome and recovery of infectious virus
The Q3928P, Q3928N and ΔQ3928 mutations/deletion were then
introduced into the IBV genome using the reverse genetic systemown are the replicase polyproteins 1a and 1ab of IBV. The processing end-products of 1a
gnated nsp2 to nsp10 and nsp12 to nsp16. The cleavage sites of IBV 3CLpro are indicated
arrow. (b) Effect of deletion and mutation of the P1 residue at the cleavage site between
2100–12729 with insertion of an extra T at position between nucleotides 12347–12348
s were harvested at 16 h post-transfection, lysates were prepared and separated on 15%
kDa) and uncleaved substrate (24.8 kDa) were indicated.
Fig. 2. (a) Analysis of the growth properties of wild type and mutant viruses. Vero cells
were infected with wild type (rIBV) and three mutant viruses Q3928N, Q3928P and
ΔQ3928 at a multiplicity of infection of approximately 1. Cells were harvested at 0, 4, 8,
12, 16, 24 and 36 h post-infection, respectively. Viral stocks were prepared by freezing/
thawing of the cells three times, and TCID50 of each viral preparationwas determined by
infection of ﬁve wells of Vero cells on 96-well plates in triplicate with 10-fold serial
dilution of each viral stock. (b) Processing of nsp10–nsp12 in wild type and mutant
viruses. Vero cells were infected with rIBV, Q3928N, Q3928P and ΔQ3928, respectively,
at a multiplicity of infection of approximately 1 for 4 h and labeled with 35S-Met-
containing medium for 16 h. Cells were harvested, lysed and proteins were
immunoprecipitated with polyclonal antiserum against IBV nsp12. After resolved by
6% SDS-PAGE, proteins were detected by ﬂuorography. Bands corresponding to nsp12
(100 kDa, nsp12) and the nsp10–nsp12 fusion protein (120 kDa, nsp10–12) are
indicated.
177Rapid Communicationpreviously described (Tan et al., 2006; Fang et al., 2007). Full-length
transcripts were generated and electroporated into Vero cells. At two
days post-electroporation, typical CPE were observed in the cells
electroporated with wild type and all mutant transcripts. When the
clariﬁed media from the electroporated cells were used to infect fresh
Vero cells, CPE was found at 16 h post-infection, conﬁrming the
production of infectious progeny viruses.
Characterization of the growth kinetics of the recovered mutant viruses
and identiﬁcation of nsp10–12 chimeric protein in cells infected with the
mutant viruses
Growth kinetics of the recovered mutant viruses Q3928P, Q3928N
and ΔQ3928 were analyzed by TCID50 assay. Compared to wild type
rIBV, Q3928P mutant virus displayed very similar growth kinetics as
the wild type virus; both viruses reached the peak at 16 h post-
infectionwith peak titer of 106 for wild type virus and a slightly lower
TCID50 for themutant virus (Fig. 2a). TheQ3928Nmutant virus reached
the peak titer of 106 at 12 hpost-infection (Fig. 2a). TheΔQ3928mutant
virus displayed approximately 10-fold lower peak TCID50 value at 16 h
post-infection (Fig. 2a). Interestingly, it was observed that this mutant
virus maintained a titer similar to the peak value up to 36 h post-
infection (Fig. 2a). All mutant viruses showed similar sized plaques in
Vero cells at 4 days post-infection (data not shown).
Radioimmunoprecipitation was then carried out to analyze the
processing of nsp10–nsp11/12 in cells infected with the mutant
viruses. A predominant cleavage product with an approximately
molecular mass of 100 kDa, representing the nsp12 protein, was
detected in cells infected with wild type rIBV (Fig. 2b, lane 2). A minor
band of approximately 120 kDa was also detected in the same cell
lysates (Fig. 2b, lane 2); it may represent the nsp10–nsp12
intermediate cleavage product. In cells infected with the Q3928P
and ΔQ3928 mutant viruses, only the 120 kDa species was detected
(Fig. 2b, lanes 4 and 5). Unexpectedly, in cells infected with the
Q3928Nmutant virus, both the 100 kDa and the 120 kDa species were
detected, although detection of slightly more 120 kDa species was
observed (Fig. 2b, lane 3), suggesting that this mutation did not
completely ablate cleavage at this position in cells infected with the
mutant virus. Attempts to detect the nsp10–11 intermediate in cells
infected with wild type and mutant viruses were unsuccessful, due to
the low quality of the available antibodies against nsp10. As a control
for the efﬁciency of IBV infection, cells infected with wild type and the
ΔQ3928 mutant virus, respectively, were analyzed by immunopreci-
pitation analysis with anti-IBV S protein antibodies, showing the
presence of glycosylated full-length (Sa), unglycosylated full-length
(Sb) species (Fig. 2b, lanes 6–8). The cleaved S1/S2 (Sc) species were
also marginally detected in this gel (Fig. 2b, lanes 6–8), and much
more clear detection of these species was obtained in longer exposed
gels (data not shown). These results conﬁrmed that either mutation of
the Q3928 residue to a Pro or deletion of the Q3928 residue totally
blocked the IBV 3CLpro-mediated cleavage at the position. However,
viable viruses with reasonably good replication efﬁciency could be
recovered from in vitro transcribed full-length RNAs containing the
mutation/deletion.
Continuous passage and genetic stability of the mutant viruses in
cultured cells
The genetic stability of these mutant viruses was then tested by
continuous propagation of the plaque-puriﬁed viruses in Vero cells to
20 passages. Total RNA was extracted from cells infected with wild
type rIBV and the mutant viruses at a multiplicity of infection of
approximately 1 and Northern blot was performed. The results
showed that no signiﬁcant difference in either the pattern of RNA
species or the ratio of RNA1 to RNA6 was found in rIBV and mutant
viruses (Fig. 3a, lanes 2–5). Nucleotide sequencing analysis of the RT-PCR products ampliﬁed from nsp10 through nsp11 conﬁrmed the
presence of the engineered mutations or deletion in the mutant
viruses (Fig. 3b). No other nucleotide changes were found in this
region (data not shown). These results conﬁrmed that the recovered
mutant viruses were stable in cultured cells.
The dispensability of cleavage at this position for IBV replication
and infectious virus recovery was further tested by creating a mutant
virus with deletion of both the P1-Q3928 and the P1′-S3929 residues
(ΔQ3928–S3929). Similarly, propagation of the plaque-puriﬁed virus
for 20 passages showed that this mutant virus was genetically stable
in cultured cells but with slightly lower growth efﬁciency than wild
type and other mutant viruses (Fig. 3a, lane 6 and Fig. 3b).
Cleavage of the polyproteins 1a and 1ab at the position between
Q3928 and S3929 by the IBV 3CLpro leads to the release of nsp10
(16 kDa), nsp11 (23 amino acids) and nsp12 (100 kDa) (Liu and Brown,
1994, Liu et al., 1997, Ng and Liu, 2002). Nsp12 encodes the putative
viral RNA-dependent RNA polymerase, a critical enzyme that directly
controls the replication and transcription of viral RNA. Coronavirus
nsp10 may function in the formation of viral replication/transcription
complexes. It was reported that IBV nsp10 may form dimers and
localize to membranes associated with RNA synthesis (Ng and Liu,
2002); and MHV nsp10 colocalizes with nsp1, nsp2, nsp5, nsp7, nsp8,
nsp9, nsp12, nsp13 and nucleocapsid protein at the site of replication
178 Rapid Communicationcomplexes (Bost et al., 2000; Brockway et al., 2003). More recently, the
protein was shown to be involved in the synthesis of MHV RNA
(Sawicki et al., 2005), by functioning as a critical regulator of viral RNA
synthesis (Donaldson et al., 2007b). Itmayalso play a role in regulation
of polyprotein processing (Donaldson et al., 2007a). Structural studies
of the SARS-CoVnsp10 showed that it is a novel zincﬁnger proteinwith
two zinc-binding motifs and 12 identical subunits assemble into a
novel functional dodecameric architecture that forms a hollow,
positively charged cylinder (Su et al., 2006; Joseph et al., 2006).
Based on this information, the protein was proposed to be a
transcription factor (Su et al., 2006). In this study, we provided
concrete genetic and biochemical evidence that proteolytic processing
at the cleavage sites between the two proteins is not required for their
functions in viral replication. It suggests that the nsp10–12 inter-
mediate may play the functions of both nsp10 and nsp12 in virus-
infected cells. It is puzzling that two such critical functional proteins
would retain their individual functionality in the form of a processing
intermediate. Interestingly, our results are in sharp contrast to a
recently reported result that processing of nsp10–nsp11/12 was
essential for MHV replication (Deming et al., 2007). The reason for
this remarkable discrepancy is not known. Nevertheless, it demon-
strates that different RNA viruses, even among viruses in the same
family, may employ totally different strategies to regulate their RNA
replication. In addition, our datawould indirectly support the proposal
that the fused nsp10–nsp11 could be crystallized into a novel
functional dodecameric architecture (Su et al., 2006).
Mutational analysis and peptide cleavage data have shown that
replacement of the conserved P2 Leu residue with a Val could
signiﬁcantly decrease the cleavage efﬁciency in several positions (Fan
et al., 2004, 2005). The nsp10–nsp11/12 site of IBV has a Val instead of
Leu residue at the P2 position and the P2 positions of nsp10–nsp11/12
in other coronaviruses are also occupied by noncanonical residues
(Ziebuhr and Siddell, 1999, Fan et al., 2004). In this study, a minute
amount of the nsp10–nsp12 intermediate was detected in cells
infected with wild type IBV. This intermediate cleavage product
would therefore maintain the functions of both nsp10 and nsp12
proteins, making it more difﬁcult to design peptide inhibitors. On theFig. 3. (a) Northern blot analysis of RNA synthesis in cells infectedwith wild type IBV and pass
infected with wild type and the mutant viruses at a multiplicity of infection of approximately
and separated on a 0.8% denatured agarose gel. After transferring to nylonmembrane, viral RN
of IBV. (b) Genetic stability of themutant viruses. Total RNAwas prepared fromVero cells infe
and the region covering mutation or deletion was ampliﬁed by RT-PCR and sequenced. Theother hand, it is reasonable to speculate that the full functions of the
two proteins may depend on one another. For example, it is not yet
conﬁrmed that nsp12 is the coronavirus RNA-dependent RNA poly-
merase due to the lack of concrete biochemical data. One possibility is
that inclusion of nsp10 in the in vitro experiment system would be
needed in order to detect the full function of nsp12, especially the
activity involved in de novo synthesis of the full-length coronavirus
RNA using puriﬁed nsp12. The fact that minute amounts of the nsp10–
12 intermediate were detected in cells infected with wild type IBV
further supports that the two proteins may function synergistically.
As the recoveredmutant viruses showed certain degrees of growth
defect, one potential application of this study is to create attenuated
viruses by deletion of the Q3928–S3929 site and the ﬂanking
sequences for development of vaccine candidates. For example,
infectious virus recovered from construct with deletion of the Q3928
residue is stable and showed slow growth kinetics with lower peak
titer. Furthermore, infectious virus with even lower replication
efﬁciency could also be recovered from construct with deletion of
both Q3928–S3929 residues. Manipulation of this position would
create attenuated viruses suitable for development of IBV vaccines
from new isolates. Meanwhile, manipulation of the same position in
other human and animal coronaviruses, such as SARS-CoV, might be
able to create attenuated viruses for the samepurpose. Further insights
into the practicality of this approach in vaccine development would be
provided by systematic studies to conﬁrm if mutant viruses generated
by this manipulation were also attenuated in pathogenesis as well as
the stability and recombination rate of the mutant viruses in animals.
Materials and methods
Cells and virus
Vero cells were cultured at 37 °C in minimal essential medium
(MEM) supplemented with 10% fetal bovine serum (FBS), penicillin
(100 units/ml), and streptomycin (100 μg/ml). Recombinant wild type
IBV (rIBV) and mutant IBV were propagated in Vero cells in FBS-free
MEM.age 20 of themutant viruses Q3928N, Q3928P andΔQ3928, respectively. Vero cells were
1, and harvested at 16 h post-infection. Total RNAwas extracted from the infected cells
As were detected by hybridizationwith a DIG-labeled DNA probe speciﬁc for the 3′-UTR
ctedwith passage 20 of themutant virus Q3928N, Q3928P, ΔQ3928 and ΔQ3928–S3929,
changed or deleted nucleotides were indicated.
179Rapid CommunicationTransient expression and processing in mammalian cells
ORFs placed under the control of a T7 promoter were expressed
transiently in mammalian cells using a vaccinia-T7 expression
system. Brieﬂy, conﬂuent Vero cells in 6-well plate were inoculated
with a recombinant vaccinia virus (vTF7-3) expressing T7 RNA poly-
merase. At 1 h post-infection, medium was removed and plasmids,
containing wild type or mutated cleavage site between nsp10–nsp11/
12 together with pIBV3C containing the full-length IBV 3CLpro se-
quence (Liu et al., 1997), were transfected into cells with Lipofecta-
mine 2000 transfection reagent according to the manufacturer's
instructions (Invitrogen). Cells were harvested after incubation at
37 °C for 16–20 h.
SDS-PAGE and Western blot analysis
Transfected cells were lysed with 2×SDS loading buffer containing
100 mM DTT and 5 mM of iodoacetamide, boiled at 100 °C for 5 min
and clariﬁed. The proteins were separated by 15% SDS-PAGE and were
transferred to PVDFmembrane (Bio-Rad). Themembranewas blocked
overnight at 4 °C or for 2 h at room temperature in blocking buffer
(10% fat free milk powder in PBS buffer containing 0.1% Tween-20),
and thenwas incubated with 1:1000 diluted anti-FLAG HRP (Sigma) in
blocking buffer for 2 h at room temperature. After washing three times
with PBST, the polypeptides were detected with a chemiluminescence
detection kit (ECL, Amersham Biosciences) according to the manufac-
turer's instructions.
Generation of mutant viruses
Constructs containing a single mutation of Gln3928 to Asn or Pro, a
deletion of Gln3928 or Gln3928–S3929 were produced by using
QuickChange site-directed mutagenesis kit (Stratagene). The muta-
tions were veriﬁed by automated nucleotide sequencing.
The full-length infectious clone was assembled as previously
described (Tan et al., 2006; Fang et al., 2007) by replacing the
corresponding fragment with the mutant fragment. In vitro full-
length transcripts were generated using the mMessage mMachine T7
kit (Ambion, Austin, TX) and electroporated into Vero cells with one
pulse at 450 V, 50 µF with a Bio-Rad Gene Pulser II electroporator. The
electroporated Vero cells were cultured overnight in 1% FBS-contain-
ing MEM and further cultured in MEM without FBS. The transfected
cells were monitored daily for formation of cytopathic effect (CPE),
and the recovered mutant viruses were plaque-puriﬁed and propa-
gated in Vero cells.
Northern hybridization
Vero cells were infected with wild type rIBV and the recovered
mutant viruses at a multiplicity of ∼1 PFU/cell, respectively, and 10 μg
of total RNA extracted from the infected cells was added to a mixture
of 1×MOPS, 37% formaldehyde and formamide, and incubated at 65 °C
for 20 min prior to gel electrophoresis. The separated RNA bands were
transferred onto a Hybond N+ membrane (Amersham Biosciences) via
capillary action overnight and ﬁxed by ultraviolet crosslinking
(Stratalinker). Hybridization of Dig-labeled DNA probes correspond-
ing to the IBV 3′-untranslated region from nucleotides 27104–27510
was carried out at 50 °C in hybridization buffer oven overnight.
Membranes were washed three times for 15 min each with buffers of
different stringencies and signals were detected with CDPStar (Roche)
according to the manufacturer's instructions.
Viral growth assays
Conﬂuent monolayer of Vero cells on six-well plates was infected
with recovered viruses and harvested at different times post-infection. Viral stocks were prepared by freezing/thawing of the
cells three times. The 50% tissue culture infection dose (TCID50) of each
samplewas determined by infecting ﬁvewells of Vero cells on 96-well
plates with 10-fold serial dilution of each viral stock.
Immunoprecipitation analysis
Vero cells were infected with wild type and the mutant viruses. At
2 h post-infection, the cultured media were replaced with methio-
nine-free media. After incubation for 2 h, cells were labeled with 35S-
methionine for 16 h. The labeled cells were lysed with 1 ml of RIPA
buffer (50 mM Tris–HCl, pH 7.5, 150 mM NaCl, 1% NP-40, 1% sodium
deoxycholate, and 0.1% SDS), and immunoprecipitation was per-
formed as described previously using polyclonal antibodies against
IBV S and nsp12 proteins (Liu et al., 1994).
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